Pharma Groups Pressure FDA On Drug Innovation, Access
In response to a U.S. Food and Drug Administration solicitation, leading pharmaceutical trade groups are jousting over how the agency should recalibrate the delicate balance between innovation and affordability, newly released...To view the full article, register now.
Already a subscriber? Click here to view full article